Patents Assigned to Dermapharm AG
-
Patent number: 12502307Abstract: The invention relates a device for the hyperthermal treatment of a herpes disease on a skin, preferably a lip, wherein a control device is configured to regulate a treatment surface on an outer side facing the skin by heating at least one heating element in a heating phase to a contact temperature of 43-47° C. during a contact of the treatment surface with the skin, preferably the lip, and to maintain the contact temperature in a treatment phase for a time period between 1 and 10 seconds.Type: GrantFiled: September 5, 2019Date of Patent: December 23, 2025Assignee: DERMAPHARM AGInventor: Daniel Bünger Von Wurmb
-
Patent number: 11759348Abstract: The invention relates to a device for hyperthermic treatment of itching, for example following insect bites, wherein during the treatment a treatment surface is regulated at a temperature of preferably between 42° C. and 56° C. for a period of 2 sec to 12 sec and a hardware-implemented temperature monitor limits the maximum temperature of the treatment surface and a safety fuse shuts off the device in the case of a short-circuit or uncontrolled continuous heating.Type: GrantFiled: July 12, 2017Date of Patent: September 19, 2023Assignee: DERMAPHARM AGInventor: Daniel Bünger
-
Publication number: 20220142813Abstract: The invention preferably relates to a device for hyperthermal treatment of itching and/or herpes diseases comprising a control device on which at least two treatment programs are stored and an interface for a selection of one of the at least two treatment programs by means of a mobile device, so that after actuation of an operating element the control device heats a treatment surface according to the selected treatment program to a treatment temperature between 40°-65° C. and holds the treatment temperature for a treatment duration between 1 and 12 seconds.Type: ApplicationFiled: January 23, 2020Publication date: May 12, 2022Applicant: DERMAPHARM AGInventor: Daniel BÜNGER VON WURMB
-
Publication number: 20210322204Abstract: The invention relates a device for the hyperthermal treatment of a herpes disease on a skin, preferably a lip, wherein a control device is configured to regulate a treatment surface on an outer side facing the skin by heating at least one heating element in a heating phase to a contact temperature of 43-47° C. during a contact of the treatment surface with the skin, preferably the lip, and to maintain the contact temperature in a treatment phase for a time period between 1 and 10 seconds.Type: ApplicationFiled: September 5, 2019Publication date: October 21, 2021Applicant: DERMAPHARM AGInventor: Daniel BÜNGER VON WURMB
-
Publication number: 20210322205Abstract: The invention relates to a device for treating itching and/or herpes disease on a skin, wherein a control device is configured to regulate a treatment surface on an outer side facing the skin by heating at least one heating element in a heating phase to a contact temperature during a contact of the treatment surface with the skin and to maintain the temperature in a treatment phase, and wherein the device comprises at least one contact sensor.Type: ApplicationFiled: September 5, 2019Publication date: October 21, 2021Applicant: DERMAPHARM AGInventor: Daniel BÜNGER VON WURMB
-
Publication number: 20210236327Abstract: In a first aspect, the invention relates to a device for hyperthermal treatment of itching comprising at least one treatment surface which can be heated by heating at least one heating element to a treatment temperature of 40° C. to 65° C. and can be controlled by a control device, wherein the device exhibits at least one interface and is configured for a power supply of the device by a mobile device and/or for data exchange with a mobile device and/or for control by a mobile device via the interface. In a further aspect, the invention relates to a system comprising the device and a mobile device, wherein the device is configured for a power supply by the mobile device and/or for data exchange with the mobile device and/or for control by the mobile device via an interface.Type: ApplicationFiled: June 6, 2019Publication date: August 5, 2021Applicant: DERMAPHARM AGInventor: Daniel BÜNGER VON WURMB
-
Patent number: D923806Type: GrantFiled: December 18, 2019Date of Patent: June 29, 2021Assignee: Dermapharm AGInventors: Daniel Bünger von Wurmb, Josef Prasser
-
Patent number: D930845Type: GrantFiled: July 23, 2019Date of Patent: September 14, 2021Assignee: Dermapharm AGInventors: Colin Schmidt, Qiong Zhang
-
Patent number: D963175Type: GrantFiled: February 2, 2021Date of Patent: September 6, 2022Assignee: Dermapharm AGInventors: Daniel Bünger von Wurmb, Camill Maier
-
Patent number: D963176Type: GrantFiled: February 2, 2021Date of Patent: September 6, 2022Assignee: Dermapharm AGInventors: Daniel Bünger von Wurmb, Camill Maier
-
Patent number: D1105458Type: GrantFiled: January 16, 2024Date of Patent: December 9, 2025Assignee: Dermapharm AGInventor: Alexander Grimm
-
Patent number: D1112777Type: GrantFiled: January 16, 2024Date of Patent: February 10, 2026Assignee: Dermapharm AGInventor: Alexander Grimm
-
Patent number: D1114280Type: GrantFiled: October 17, 2023Date of Patent: February 17, 2026Assignee: Dermapharm AGInventor: Alexander Grimm